A.W.S. Ritchie

9.4k citations
108 papers · 7.5k · 5 hit papers · h-index 31

Impact in

Papers in

    • Renal cell carcinoma treatment 29
    • Prostate Cancer Treatment and Research 25
    • Prostate Cancer Diagnosis and Treatment 19
    • Kidney Stones and Urolithiasis Treatments 8
    • Bladder and Urothelial Cancer Treatments 4

A.W.S. Ritchie

106 papers receiving 7.2k citations

A.W.S. Ritchie's Hit Papers

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial 2019 · 315 citations
3150+4+8Years since publication5001k1.5k

Peers

A.W.S. Ritchie
Comparison fields: 5 of 107
  • Pulmonary and Respiratory Medicine 5.5k
  • Oncology 473
  • Statistics and Probability 264
  • Reproductive Medicine 164
  • Cancer Research 176
Replace Andrew J. Stephenson with:
Andrew J. Stephenson United States
Pavlos Msaouel United States
Gina R. Petroni United States
Carol Jane Swallow Canada
Derick H. Lau United States
Najat C. Daw United States
Stephan D. Voss United States
James J. Rusthoven Canada
Richard I. Whyte United States
Eric Jonasch United States
A.W.S. Ritchie relative to Andrew J. Stephenson United States Andrew J. Stephenson's profile →
Citations per field
00.5×2×4×6.1×
Andrew J. Stephenson · 1×
Citations per year

Countries citing papers authored by A.W.S. Ritchie

Since Specialization
Citations

This map shows the geographic impact of A.W.S. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.W.S. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.W.S. Ritchie more than expected).

Fields of papers citing papers by A.W.S. Ritchie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.W.S. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.W.S. Ritchie. The network helps show where A.W.S. Ritchie may publish in the future.

Co-authors

The 25 scholars most cited alongside A.W.S. Ritchie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.W.S. Ritchie Line = papers co-authored together A.W.S. Ritchie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Hit paper breakdown →
20151553
2
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Hit paper breakdown →
20171368
3
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Hit paper breakdown →
2018912
4
Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Hit paper breakdown →
2014329
5
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
Hit paper breakdown →
2019315
6 2018199
7 1983176
8 2019170
9 2015148
10
The natural history of renal carcinoma.
1983137
11 2012134
12 1985118
13 1984100
14 201299
15 202097
16
The natural history and clinical features of renal carcinoma.
198790
17 198868
18
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1.
198367
19 202265
20 198760

About A.W.S. Ritchie

A.W.S. Ritchie is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Statistics and Probability, Immunology and Biophysics, having authored 108 papers that have together received 7.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (29 papers), Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (19 papers), Kidney Stones and Urolithiasis Treatments (8 papers), Bladder and Urothelial Cancer Treatments (4 papers), Statistical Methods in Clinical Trials (4 papers), Immune Cell Function and Interaction (3 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.5k citations), Oncology (473 citations), Statistics and Probability (264 citations), Reproductive Medicine (164 citations) and Cancer Research (176 citations). A.W.S. Ritchie has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include K. James, G. D. CHISHOLM, G. D. Chisholm, H. Spedding Micklem, J B deKernion, Mahesh Parmar, Nicholas David James, Matthew Robert Sydes, Noel William Clarke and David Paul Dearnaley. Their work appears in journals such as Annals of Oncology, The Journal of Urology, The Lancet, European Urology and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact